Karen Berry

1.0k total citations
12 papers, 755 citations indexed

About

Karen Berry is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Karen Berry has authored 12 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Karen Berry's work include T-cell and B-cell Immunology (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Karen Berry is often cited by papers focused on T-cell and B-cell Immunology (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Karen Berry collaborates with scholars based in United States, Germany and Australia. Karen Berry's co-authors include Gerald G. Krueger, Nicholas J. Lowe, Michael Goldfarb, Russell Weiner, James G. Krueger, Mark Lebwohl, Martin Birkhofer, Garvin L. Warner, Alan Menter and Sewon Kang and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and The FASEB Journal.

In The Last Decade

Karen Berry

11 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Berry United States 9 471 175 144 127 85 12 755
U Kyan-Aung United Kingdom 8 472 1.0× 86 0.5× 177 1.2× 111 0.9× 120 1.4× 8 1.1k
Eugene S. Medlock United States 13 487 1.0× 187 1.1× 302 2.1× 31 0.2× 56 0.7× 25 878
John C. Minnerly United States 8 229 0.5× 232 1.3× 153 1.1× 278 2.2× 29 0.3× 11 745
Éva Pócsik Hungary 13 344 0.7× 158 0.9× 166 1.2× 114 0.9× 35 0.4× 30 612
Kursteen S. Price United States 10 512 1.1× 91 0.5× 208 1.4× 62 0.5× 54 0.6× 12 857
Julie A. Lucas United States 14 695 1.5× 353 2.0× 217 1.5× 91 0.7× 45 0.5× 16 1.1k
Mendy Miller United States 14 466 1.0× 98 0.6× 233 1.6× 49 0.4× 34 0.4× 21 770
Parwaresch Mr Germany 13 252 0.5× 432 2.5× 152 1.1× 92 0.7× 72 0.8× 39 881
Fumi Miyagawa Japan 15 587 1.2× 294 1.7× 240 1.7× 215 1.7× 48 0.6× 52 1.2k
Taher E. Taher United Kingdom 15 405 0.9× 92 0.5× 123 0.9× 190 1.5× 83 1.0× 23 669

Countries citing papers authored by Karen Berry

Since Specialization
Citations

This map shows the geographic impact of Karen Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Berry more than expected).

Fields of papers citing papers by Karen Berry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Berry. The network helps show where Karen Berry may publish in the future.

Co-authorship network of co-authors of Karen Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Berry. A scholar is included among the top collaborators of Karen Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Berry. Karen Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Lin, Zhonghua, Linda Rangell, Franklin Fuh, et al.. (2008). Characterization of B cell subsets in cynomolgus monkeys. The FASEB Journal. 22(S1).
3.
Cleaveland, Jeffrey S., Laura S. Grosmaire, Karen Berry, et al.. (2000). A d -Amino Acid Peptide Inhibitor of NF-κB Nuclear Localization Is Efficacious in Models of Inflammatory Disease. The Journal of Immunology. 165(2). 1004–1012. 49 indexed citations
4.
Lebwohl, Mark, Cynthia Guzzo, Brian V. Jegasothy, et al.. (1999). CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. Journal of Clinical Investigation. 103(9). 1243–1252. 473 indexed citations
5.
Loy, James, et al.. (1999). Oncostatin M: Development of a Pleiotropic Cytokine. Toxicologic Pathology. 27(2). 151–155. 16 indexed citations
6.
Srinivas, Nuggehally R., Russell Weiner, Karen Berry, Lee K. Tay, & Wen Chyi Shyu. (1998). Pharmacokinetics and Pharmacodynamics of CTLA4Ig (BMS‐188667), a Novel Immunosuppressive Agent, After Subcutaneous and Intravenous Administration to Mice. Pharmacy and Pharmacology Communications. 4(7). 355–360. 1 indexed citations
7.
8.
Frazier, Marsha L., E. Fernández, Rafael de Llorens, et al.. (1996). Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells. International Journal of Gastrointestinal Cancer. 19(1). 31–38. 29 indexed citations
9.
Huang, Suyun, Rakesh K. Singh, Keping Xie, et al.. (1994). Expression of theJE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunology Immunotherapy. 39(4). 231–238. 77 indexed citations
10.
Singh, Rakesh K., Keping Xie, Mordechai Gutman, et al.. (1994). Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunology Immunotherapy. 39(4). 231–238. 10 indexed citations
11.
Atkinson, James B., Richard L. Hoover, Karen Berry, & Larry L. Swift. (1989). Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis. Atherosclerosis. 78(2-3). 123–136. 43 indexed citations
12.
Kretchmer, Norman, et al.. (1979). Sucrase and Cellular Development. Novartis Foundation symposium. 117–131. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U Kyan-Aung Breakdown of academic impact, for papers by Eugene S. Medlock Breakdown of academic impact, for papers by John C. Minnerly Breakdown of academic impact, for papers by Éva Pócsik Breakdown of academic impact, for papers by Kursteen S. Price Breakdown of academic impact, for papers by Julie A. Lucas Breakdown of academic impact, for papers by Mendy Miller Breakdown of academic impact, for papers by Parwaresch Mr Breakdown of academic impact, for papers by Fumi Miyagawa Breakdown of academic impact, for papers by Taher E. Taher
Rankless by CCL
2026